Location History:
- Issurtille, FR (2004)
- Brussels, BE (1999 - 2008)
- Thurey, FR (2006 - 2008)
- Marcy l'Etoile, FR (2008)
Company Filing History:
10 out of 525 
1 out of 185 
3 out of 832,891 Years Active: 1999-2008
Title: The Innovative Contributions of Pascal Chaux
Introduction
Pascal Chaux is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his work on tumor-associated peptides. With a total of 13 patents to his name, Chaux has established himself as a key figure in the development of innovative diagnostic and therapeutic methods.
Latest Patents
Chaux's latest patents include groundbreaking inventions related to MAGE peptides presented by HLA class II molecules. This invention describes HLA class II binding peptides encoded by the MAGE tumor-associated genes. These peptides stimulate the activity and proliferation of CD4T lymphocytes, which are crucial for immune response. Additionally, methods and products are provided for diagnosing and treating conditions characterized by the expression of MAGE genes. Another notable patent is focused on MAGE-A3 peptides presented by HLA class II molecules. This invention similarly describes HLA class II binding peptides encoded by the MAGE-A3 tumor-associated gene, along with nucleic acids and antibodies related to these peptides. The implications of this work are significant for diagnosing and treating conditions associated with the MAGE-A3 gene.
Career Highlights
Throughout his career, Pascal Chaux has worked with esteemed organizations, including the Ludwig Institute for Cancer Research Limited. His work has been instrumental in advancing the understanding of cancer immunology and developing new therapeutic strategies.
Collaborations
Chaux has collaborated with notable colleagues such as Pierre Van Der Bruggen and Thierry R Boon-Falleur. These collaborations have further enriched his research and contributed to the success of his innovative projects.
Conclusion
Pascal Chaux's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnosis and treatment.